Company profile
ANGIODYNAMICS INC
NASDAQ:ANGOMedical/Dental Instruments
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03899636 | phase3 | active_not_recruiting | 2021-02-23 | 2025-04-01 | Angiodynamics, Inc. | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer |
FDA applications (0)
No records yet.